MARC Record from marc_columbia

LEADER: 06289fam a2200469 a 4500
001 4048203
005 20221027024318.0
008 950109t19951995nyua b 001 0 eng c
010 $a 95003691
020 $a0896402681
020 $a4260142682
035 $a(OCoLC)60272623
035 $a(OCoLC)ocm60272623
035 $9AKS8738HS
035 $a(NNC)4048203
035 $a4048203
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB
050 00 $aRC847$b.T487 1995
060 00 $aWI 700 T535d 1995
082 00 $a616.3/62075$220
100 1 $aThung, Swan N.$0http://id.loc.gov/authorities/names/n95800375
245 10 $aLiver disorders /$cSwan N. Thung, Michael A. Gerber.
260 $aNew York :$bIgaku-Shoin,$c[1995], ©1995.
300 $axi, 180 pages :$billustrations ;$c29 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aDifferential diagnosis in pathology
504 $aIncludes bibliographical references and index.
505 0 $a1. Acute Hepatitis vs Chronic Hepatitis -- 2. Acute Viral Hepatitis: Hepatotropic vs Nonhepatotropic Viruses -- 3. Mild Acute or Residual Hepatitis vs Nonspecific Reactive Hepatitis -- 4. Acute Viral Hepatitis vs Drug-Induced Hepatitis -- 5. Acute Hepatitis with Massive Hepatic Necrosis vs Toxic Necrosis vs Shock Liver -- 6. Acute Viral Hepatitis vs Alcoholic Hepatitis -- 7. Liver Disease in Pregnancy -- 8. Sepsis vs Surgery-Associated Changes -- 9. Large Bile Duct Obstruction vs Toxic Shock vs Septic Cholangitis -- 10. Cholestatic Hepatitis vs Large Bile Duct Obstruction -- 11. Alcoholic Hepatitis vs Nonalcoholic Steatohepatitis -- 12. Alcoholic Hepatitis vs Drug-Induced Phospholipidosis -- 13. Alcoholic Central Hyalin Sclerosis vs Chronic Passive Congestion -- 14. Budd-Chiari Syndrome or Venoocclusive Disease vs Chronic Passive Congestion -- 15. Chronic Budd-Chiari Syndrome or Venoocclusive Disease vs Alcoholic Central Hyalin Sclerosis.
505 8 $a16. Chronic Persistent Hepatitis vs Chronic Active Hepatitis vs Chronic Lobular Hepatitis vs New Classification -- 17. Autoimmune Hepatitis vs Chronic Hepatitis C vs Chronic Hepatitis B -- 18. Chronic Hepatitis vs Wilson's Disease -- 19. Chronic Hepatitis vs [actual symbol not reproducible] Deficiency -- 20. Chronic Hepatitis vs Lymphoma -- 21. Chronic Hepatitis vs Primary Biliary Cirrhosis -- 22. Chronic Hepatitis vs Primary Sclerosing Cholangitis -- 23. Primary Biliary Cirrhosis vs Primary Sclerosing Cholangitis -- 24. Primary Biliary Cirrhosis vs Large Bile Duct Obstruction and Secondary Biliary Cirrhosis -- 25. Drug-Induced Cholestatic Hepatitis vs Primary Biliary Cirrhosis vs Primary Sclerosing Cholangitis -- 26. Fibropolycystic Disease of the Liver vs Primary Biliary Cirrhosis -- 27. Caroli's Disease vs Polycystic Liver Disease vs Biliary Microhamartoma -- 28. Dubin-Johnson Syndrome vs Atrophy of the Liver -- 29. Differentiation of Brown Pigments in the Liver.
505 8 $a30. Genetic Hemochromatosis vs Secondary Iron Overload -- 31. Diagnosis of Cirrhosis: Definite vs Suggestive Criteria -- 32. Cirrhosis vs Precirrhotic Conditions -- 33. Cirrhosis vs Hepatitis with Bridging Necrosis -- 34. Alcoholic Cirrhosis vs Nonalcoholic Cirrhosis -- 35. Cirrhosis vs Nodular Regenerative Hyperplasia of Liver -- 36. Cellular (Acute) Liver Allograft Rejection vs "Harvesting" Injury vs Biliary Tract Complications -- 37. Acute Hepatitis vs Cellular (Acute) Liver Allograft Rejection -- 38. Chronic Hepatitis vs Graft-vs-Host Disease in Transplant Patients -- 39. Cellular (Acute) Liver Allograft Rejection vs Chronic Liver Allograft Rejection -- 40. Cytomegaloviral Hepatitis vs Cellular (Acute) Liver Allograft Rejection -- 41. Cytomegaloviral Hepatitis vs Herpes Simplex Hepatitis -- 42. Epstein-Barr Viral Hepatitis vs Posttransplant Lymphoproliferative Disease vs Cellular (Acute) Liver Allograft Rejection -- 43. Chronic Hepatitis in Liver Allografts vs Chronic Rejection.
505 8 $a44. Hepatic Granulomata -- 45. Cavernous Hemangioma vs Peliosis Hepatitis -- 46. Angiomyolipoma vs Focal Steatosis -- 47. Bile Duct Adenoma vs Biliary Microhamartoma vs Intrahepatic Cholangiocarcinoma -- 48. Focal Nodular Hyperplasia vs Cirrhosis -- 49. Focal Nodular Hyperplasia vs Hepatocellular Adenoma -- 50. Hepatocellular Adenoma vs Macroregenerative Nodule vs Small Hepatocellular Carcinoma -- 51. Tumor-Associated Changes vs Nonspecific Reactive Hepatitis vs Large Bile Duct Obstruction -- 52. Adenocarcinoma vs Proliferating Bile Ductules vs Ductular Hepatocytes -- 53. Intrahepatic Cholangiocarcinoma vs Metastatic Adenocarcinoma -- 54. Biliary Cystadenocarcinoma vs Intrahepatic Cholangiocarcinoma -- 55. Intrahepatic Cholangiocarcinoma vs Epithelioid Hemangioendothelioma -- 56. Epithelioid Hemangioendothelioma vs Angiosarcoma -- 57. Hepatocellular Carcinoma vs Metastatic Tumor -- 58. Hepatocellular Carcinoma vs Intrahepatic Cholangiocarcinoma vs Cholangiohepatocellular Carcinoma.
505 8 $a59. Hepatocellular Carcinoma vs Fibrolamellar Carcinoma -- 60. Neonatal Hepatitis vs Paucity of Intrahepatic Bile Ducts vs Large Bile Duct Obstruction or Biliary Atresia -- 61. Fulminant Viral Hepatitis vs Reye's Syndrome and Microvesicular Steatosis -- 62. Cholestatic Hepatitis vs Total Parenteral Nutrition-Induced Cholestatic Liver Disease -- 63. Congenital Hepatic Fibrosis vs Cirrhosis vs Prolonged Large Bile Duct Obstruction -- 64. Genetic Metabolic Disorders vs Nonmetabolic Diseases -- 65. Hepatocellular Carcinoma vs Hepatoblastoma.
650 0 $aLiver$xDiseases$xDiagnosis.$0http://id.loc.gov/authorities/subjects/sh85077756
650 0 $aDiagnosis, Differential.$0http://id.loc.gov/authorities/subjects/sh85037493
650 12 $aLiver Diseases$xpathology.$0https://id.nlm.nih.gov/mesh/D008107Q000473
650 22 $aBile Duct Diseases$xpathology.$0https://id.nlm.nih.gov/mesh/D001649Q000473
650 22 $aBile Ducts, Intrahepatic$xpathology.$0https://id.nlm.nih.gov/mesh/D001653Q000473
650 22 $aDiagnosis, Differential.$0https://id.nlm.nih.gov/mesh/D003937
700 1 $aGerber, Michael A.,$d1939-$0http://id.loc.gov/authorities/names/n95800376
830 0 $aDifferential diagnosis in pathology.$0http://id.loc.gov/authorities/names/n88525798
852 00 $boff,hsl$hRC847$i.T487 1995 Q